Elicio Therapeutics, Inc. - 8-K Filing

Elicio Therapeutics, Inc. concludes 2026 annual meeting of stockholders with approval of director nominees and auditor ratification. (Items: 5.07 Submission of Matters to a Vote of Security Holders)

SEC EDGAR ·

Tickers: $ELTX

Read the full article at SEC EDGAR

More Regulatory news